Voyager Therapeutics Inc.
(VYGR)
undefined
undefined%
At close: undefined
5.73
0.09%
After-hours Jan 08, 2025, 04:00 PM EST
Income Statement (Annual)
Get detailed income statement breakdowns, uncovering revenue, expenses, and much more.
| Year | FY23 | FY22 | FY21 | FY20 | FY19 | FY18 | FY17 | FY16 | FY15 | FY14 | FY13 |
| Revenue | 250.01M | 40.91M | 37.41M | 171.13M | 104.39M | 7.62M | 10.13M | 14.22M | 17.33M | n/a | n/a |
| Cost of Revenue | 4.44M | 6.19M | 73.79M | 108.75M | 119.73M | 64.91M | 62.26M | 42.25M | 27.68M | 8.90M | 4.63M |
| Gross Profit | 245.57M | 34.72M | -36.37M | 62.38M | -15.34M | -57.29M | -52.13M | -28.03M | -10.35M | -8.90M | -4.63M |
| Operating Income | 122.01M | -50.84M | -73.62M | 27.38M | -51.68M | -91.09M | -71.86M | -41.30M | -20.25M | -14.37M | -7.53M |
| Interest Income | 11.72M | 1.79M | 390.00K | 1.66M | 6.46M | n/a | 1.23M | n/a | n/a | n/a | 134.00K |
| Pretax Income | 133.74M | -46.39M | -71.20M | 36.74M | -43.60M | -88.47M | -70.70M | -40.14M | -29.67M | -16.32M | -7.67M |
| Net Income | 132.33M | -46.41M | -66.03M | 36.74M | -40.83M | -88.29M | -70.70M | -40.19M | -29.67M | -16.32M | -7.67M |
| Selling & General & Admin | 35.82M | 30.98M | 37.25M | 34.99M | 36.34M | 33.81M | 19.74M | 13.27M | 9.91M | 5.47M | 2.90M |
| Research & Development | 92.17M | 60.76M | 73.79M | 108.75M | 119.73M | 64.91M | 62.26M | 42.25M | 27.68M | 8.90M | 4.63M |
| Other Expenses | n/a | 4.45M | 2.42M | 7.70M | 8.08M | 2.63M | 1.17M | 1.16M | -9.42M | n/a | n/a |
| Operating Expenses | 127.99M | 91.74M | 111.03M | 143.74M | 156.07M | 98.71M | 82.00M | 55.52M | 37.59M | 14.37M | 2.90M |
| Interest Expense | n/a | 1.79M | n/a | n/a | n/a | n/a | n/a | 976.00K | 332.00K | n/a | n/a |
| Selling & Marketing Expenses | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
| Cost & Expenses | 127.99M | 91.74M | 111.03M | 143.74M | 156.07M | 98.71M | 82.00M | 55.52M | 37.59M | 14.37M | 7.53M |
| Income Tax | 1.41M | 16.00K | -5.17M | -1.66M | -2.77M | -180.00K | -1.59M | 52.00K | -600.00K | n/a | -134.00K |
| Shares Outstanding (Basic) | 43.02M | 38.36M | 37.67M | 37.13M | 35.90M | 32.07M | 26.80M | 25.30M | 4.19M | 14.71M | 463.14K |
| Shares Outstanding (Diluted) | 44.57M | 38.36M | 37.67M | 37.35M | 35.90M | 32.07M | 26.80M | 25.30M | 4.19M | 14.71M | 463.14K |
| EPS (Basic) | 3.08 | -1.21 | -1.75 | 0.99 | -1.14 | -2.75 | -2.64 | -1.59 | -7.08 | -1.11 | -16.55 |
| EPS (Diluted) | 2.97 | -1.21 | -1.75 | 0.98 | -1.14 | -2.75 | -2.64 | -1.59 | -7.08 | -1.11 | -16.55 |
| EBITDA | 126.45M | -44.65M | -68.45M | 31.20M | -48.91M | -88.98M | -70.27M | -40.69M | -19.65M | -14.18M | n/a |
| Depreciation & Amortization | 4.44M | 6.19M | 5.17M | 3.82M | 2.77M | 2.12M | 1.59M | 612.00K | 600.00K | 184.00K | 7.53M |